Location History:
- Kaohsiung, TW (2014 - 2015)
- Taipei, TW (2001 - 2021)
- Taichung, TW (2011 - 2021)
Company Filing History:
4 out of 10 
4 out of 1,716 
3 out of 3 
Years Active: 2001-2021
Title: Innovations and Contributions of Yueh-Hsiung Kuo in Cancer Research
Introduction: Yueh-Hsiung Kuo is a notable inventor based in Taipei, Taiwan, with an impressive portfolio of 22 patents. His work primarily focuses on the development of innovative methods and compounds for cancer treatment, showcasing significant advancements in biomedical research.
Latest Patents: Among his latest patents is the invention titled "Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor metastasis." This method involves administering an effective amount of a specific compound to a subject in need, aimed at suppressing tumor metastasis. Furthermore, this patent outlines a process for treating cancer by combining a chemotherapy agent with the aforementioned compound, leading to the creation of pharmaceutical compositions designed for both suppressing tumor metastasis and treating cancer.
Another notable patent from Kuo is related to "Caffeic acid derivatives for anti-angiogenesis." This innovation includes a series of methyl caffeate derivatives that exhibit biological activity in preventing angiogenesis. The findings suggest that these compounds inhibit angiogenesis by regulating VEGF/VEGFR-2 and its downstream signaling cascades in vascular endothelial cells.
Career Highlights: Throughout his career, Kuo has made substantial contributions to cancer research and treatment through his inventions. His expertise in pharmacology and medicinal chemistry has propelled advancements in the development of compounds aimed at combating cancer.
Collaborations: Kuo has collaborated with several professionals in his field, including Bi-Fong Lin and Chun-Ching Shih. Their joint efforts have significantly enhanced the F research output and innovation within their respective organizations.
Conclusion: Yueh-Hsiung Kuo's contributions to cancer research through his patents reflect a deep commitment to improving therapeutic options for cancer patients. His innovative inventions and collaborations will undoubtedly continue to make an impact in the field of biomedical research and drug development.